Article

STAAR Surgical markets phakic IOL in Canada

The Canadian Therapeutic Products Directorate said it granted approval for STAAR Surgical Co. to market its STAAR Visian Toric lens (TICL) in Canada.

The Canadian Therapeutic Products Directorate said it granted approval for STAAR Surgical Co. to market its STAAR Visian Toric lens (TICL) in Canada.

The posterior chamber phakic IOL is the first to be approved to correct both myopia and astigmatism in a single procedure, the company said in a prepared statement.

Used as part of the customized refractive procedure, the IOL offers a solution that corrects these vision deficiencies without the removal or destruction of corneal tissue, according to the company.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.